donepezil + placebo

This entry refers to the combination of donepezil and placebo, typically used in clinical trial settings as a comparison arm rather than as a therapeutic product. Donepezil is an acetylcholinesterase inhibitor indicated for the treatment of dementia associated with Alzheimer's disease. It works by reversibly inhibiting acetylcholinesterase, thereby increasing levels of acetylcholine in the brain and improving cognitive function such as memory, attention, and daily living activities. Placebo is an inert substance with no pharmacological effect, used to assess the efficacy and safety of active drugs in controlled studies. The combination "donepezil + placebo" does not represent a marketed pharmaceutical product but rather denotes two separate arms or interventions within clinical research.

Other names

placebo + donepezil-Samsung Medical Center-Alzheimer's diseasePlacebo + Donepezil 5mg or 10mgplacebo plus donepezil